Pivotal Clinical ApS: Financial statements 2020
CVR: 40343040
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Pivotal Clinical ApS (CVR 40343040) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 50,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 50,000
- Total Assets
- DKK 50,000
Official annual report
How creditworthy is Pivotal Clinical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Pivotal Clinical ApS has published its interim report for the period March 6, 2019 to December 31, 2019.
About Pivotal Clinical ApS
Pivotal Clinical ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ibrahim Naman Farr Juri. The company is owned by Pivotal S.L.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -75 and a net result of DKK -82 compared with DKK -32 the year before. Equity in the 2025 report amounted to DKK 49,886.